ACTIVATION OF THE PHOSPHOLIPASE CYCLOOXYGENASE CASCADE IN THE RABBIT CORNEA BY PLATELET-ACTIVATING-FACTOR IS CHALLENGED BY PAF RECEPTOR ANTAGONISTS

被引：12

作者：

HURST, JS ^{[1
]}

BAZAN, HEP ^{[1
]}

机构：

[1] LOUISIANA STATE UNIV,MED CTR,SCH MED,CTR EYE,NEW ORLEANS,LA 70112

来源：

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | 1995年 / 11卷 / 03期

关键词：

D O I：

10.1089/jop.1995.11.329

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Platelet-activating factor (PAF) is a potent lipid inflammatory mediator which is generated in the cornea after injury. Its activity is regulated by interaction with specific receptors. The binding of PAF to its receptors initiates biochemical sequences that cluminate in the release of additional lipid mediators. An arachidonoyl-dependent phospholipase A(2) is activated to release arachidonic acid from membrane phospholipids, especially phosphatidylcholine and ethanolamine. Arachidonic acid is then predominantly metabolized by the cyclooxygenase pathway to prostagiandins F-2 alpha, E(2) and D-2, whereas the lipoxygenase pathway is not influenced by PAF. The release of arachidonic acid and prostaglandins stimulated by PAF is challenged by the PAF receptor antagonists BN 50727 and BN 50730. PAF acting intracellularly may also induce the synthesis of cyclooxygenase, presumably the 'inducible' isoform PGHS2, which has been implicated in the inflammatory response. Thus, the therapeutic use of PAF receptor angatonists could be potentially beneficial in the management of ocular inflammatory disease.

引用

页码：329 / 337

页数：9

共 39 条

[31]

Bazan N.G., Squinto S.P., Braquet P., Panetta T., Marcheselli V.L., Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: Intracellular PAF-binding sites and activation of a Fos/Jun/Ap-1transcriptional signaling system, Lipids., 26, pp. 1236-1242, (1991)

[32]

Bazan N.G., Fletcher B.S., Herschman H.R., Mukherjee P.K., Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene, Proc. Natl. Acad. Sci., 91, pp. 5252-5256, (1994)

[33]

Tao Y., Bazan N.G., Bazan H.E.P., Platelet-activating factor (PAF) increases prostaglandin synthase-2 (COX-2) gene expression in corneal epithelium, [Abstract] Invest. Qphthal. Vis. Sci., 36, (1995)

[34]

O'Banion M.K., Winn V.P., Yang D.A., c-DNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase, Proc. Natl. Acad. Sci., 89, pp. 4888-4892, (1992)

[35]

Hemler M.E., Cook H.W., Lands W.E.M., Prostaglandin synthesis can be triggered by lipid peroxides, Arch. Biochem. Biophvs., 193, pp. 340-345, (1979)

[36]

Bito H., Camras C.B., Gum G.G., Resul B., The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals, The Ocular Effects of Prostaglandins and Other Eicosanoids, pp. 349-368, (1989)

[37]

Abdel-Latif A.A., Release and effects of prostaglandins in ocular tissues, Prostaglandins. Leukotrienes and Fatty Acids, 44, pp. 71-82, (1991)

[38]

Sano N., Shichi H., Solubilization and characterization of PGE2 receptor in porcine ciliary epithelium, J. Ocul. Pharmacol., 10, pp. 157-166, (1994)

[39]

Bhattacherjee P., Paterson C.A., Studies on prostanoid receptors in ocular tissues, J. Ocul. Pharmacol., 10, pp. 167-175, (1994)

← 1 2 3 4 →